Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip

Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip

Abstract Objective Osteoarthritis (OA) causes significant musculoskeletal pain. This study assessed the efficacy and safety of fasinumab, an investigational nerve growth factor inhibitor, in patients with moderate-to-severe OA pain of the knee/hip. Methods In this Phase 3, randomized, double-blind,...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephen J. DiMartino, Haitao Gao, Simon Eng, Guillermo Valenzuela, Thomas Fuerst, Chetachi Emeremni, Tina Ho, Hazem E. Hassan, Kenneth C. Turner, John D. Davis, Souhil Zaim, Jesse Chao, Yamini Patel, Lillian Brener, Ngan Trinh, Garen Manvelian, Michael Fetell, Ned Braunstein, Gregory P. Geba, Paula Dakin
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Musculoskeletal Disorders
Subjects:
Fasinumab
NGF inhibitor
NSAID
Osteoarthritis
Pain
Online Access:https://doi.org/10.1186/s12891-025-08402-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12891-025-08402-8

Similar Items